State Medicaid DUR Board Meeting - Revision 2
This is a Notice Revision
You are currently viewing a revision of a notice. This is a previous copy of a notice that has been published more recently. To view the current version of this notice, click here.
Please Note: Only the files that were associated to this version are included in the Download Attachments section. If that section does not display, all attachments were removed from this version of the notice.
General Information
- Government Type
- State Agency
- Entity
- Department of Health and Human Services (DHHS)
- Public Body
- Drug Utilization Review Board
Notice Information
- Notice Title
- State Medicaid DUR Board Meeting
- Notice Type(s)
- Meeting
- Event Start Date & Time
- April 9, 2026 07:15 AM
- Event End Date & Time
- April 9, 2026 08:30 AM
- Event Deadline Date & Time
- 04/09/26 08:30 AM
- Description/Agenda
- Drug Utilization Review Board Meeting Agenda Thursday, April 9, 2026 7:15 a.m. to 8:30 a.m. Google Meet joining info Video call link: meet.google.com/qbv-rjpz-fst Or dial: (US) +1 314-474-3014 PIN: 334 496 072# Persons who wish to address the DUR Board may contact Luis Moreno at lmoreno@utah.gov at least 48 hours prior to the meeting, or sign up to provide comments at the meeting. Public comments will be limited to 3 minutes per speaker or organization due to time constraints. 1) Call to order - Sharon Weinstein, MD a) Welcome and Introductions b) Review and Approval of Minutes c) Housekeeping - Ngan Huynh, PharmD 2) Prior Authorization Updates - Ngan Huynh, PharmD 3) Review Topic a) Economic Value of GLP-1 Receptor Agonists Approved for the Treatment of Obesity - Monet Luloh, PharmD i) Committee Discussion/Questions 4) Public Comment 5) Review New Prior Authorization Criteria a) Kisunla (donanemab-azbt) - Iris Wan, PharmD i) Committee Discussion/Questions ii) Committee Action b) Agamree (vamorolone) - Ngan Huynh, PharmD i) Committee Discussion/Questions ii) Committee Action c) IBAT Inhibitors (Bylvay, Livmarli) - Kyu Yun Park, PharmD i) Committee Discussion/Questions ii) Committee Action d) iDose TR (travoprost intracameral implant) - Ngan Huynh, PharmD i) Committee Discussion/Questions ii) Committee Action 6) Next Meeting a) Date: May 14, 2026 b) Topic: New prior authorization form reviews: Imaavy, Pivya, and Itvisma 7) Adjourned - Sharon Weinstein, MD
- Notice of Special Accommodations (ADA)
- In compliance with the Americans with Disabilities Act, individuals needing special accommodations (including auxiliary communicative aids and services) during this meeting should notify Luis Moreno at 801-538-6155.
- Notice of Electronic or Telephone Participation
- Video call link: meet.google.com/qbv-rjpz-fst Or dial: (US) +1 314-474-3014 PIN: 334 496 072#
Meeting Information
- Meeting Location
-
Video/Teleconferencing
Video/Teleconferencing, UT 84116
Show in Apple Maps Show in Google Maps - Contact Name
- Luis Moreno
- Contact Email
- lmoreno@utah.gov
- Contact Phone
- 801-538-6155
Notice Posting Details
- Notice Posted On
- March 26, 2026 01:58 PM
- Notice Last Edited On
- March 27, 2026 04:49 PM
- Deadline Date
- April 9, 2026 08:30 AM